Multi-institutional evaluation of MVCT guided patient registration and dosimetric precision in total marrow irradiation: A global health initiative by the international consortium of total marrow irradiation.


Journal

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
ISSN: 1879-0887
Titre abrégé: Radiother Oncol
Pays: Ireland
ID NLM: 8407192

Informations de publication

Date de publication:
12 2019
Historique:
received: 12 03 2019
revised: 09 06 2019
accepted: 08 07 2019
pubmed: 20 8 2019
medline: 27 5 2020
entrez: 19 8 2019
Statut: ppublish

Résumé

Total marrow irradiation (TMI) is a highly conformal treatment of the human skeleton structure requiring a high degree of precision and accuracy for treatment delivery. Although many centers worldwide initiated clinical studies using TMI, currently there is no standard for pretreatment patient setup. To this end, the accuracy of different patient setups was measured using pretreatment imaging. Their impact on dose delivery was assessed for multiple institutions. Whole body imaging (WBI) or partial body imaging (PBI) was performed using pretreatment megavoltage computed tomography (MVCT) in a helical Tomotherapy machine. Rigid registration of MVCT and planning kilovoltage computed tomography images were performed to measure setup error and its effect on dose distribution. The entire skeleton was considered the planning target volume (PTV) with five sub regions: head/neck (HN), spine, shoulder and clavicle (SC), and one avoidance structure, the lungs. Sixty-eight total patients (>300 images) across six institutions were analyzed. Patient setup techniques differed between centers, creating variations in dose delivery. Registration accuracy varied by anatomical region and by imaging technique, with the lowest to the highest degree of pretreatment rigid shifts in the following order: spine, pelvis, HN, SC, and lungs. Mean fractional dose was affected in regions of high registration mismatch, in particular the lungs. MVCT imaging and whole body patient immobilization was essential for assessing treatment setup, allowing for the complete analysis of 3D dose distribution in the PTV and lungs (or avoidance structures).

Identifiants

pubmed: 31421913
pii: S0167-8140(19)33000-2
doi: 10.1016/j.radonc.2019.07.010
pmc: PMC8819916
mid: NIHMS1771121
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

275-282

Subventions

Organisme : NCI NIH HHS
ID : P30 CA033572
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA154491
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Références

Biol Blood Marrow Transplant. 2006 Mar;12(3):306-15
pubmed: 16503500
Strahlenther Onkol. 2012 Apr;188(4):346-52
pubmed: 22398931
Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):876-84
pubmed: 16199317
Biol Blood Marrow Transplant. 2017 Apr;23(4):618-624
pubmed: 28087456
Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):148-56
pubmed: 22592050
Int J Radiat Oncol Biol Phys. 2001 Dec 1;51(5):1400-9
pubmed: 11728701
Radiother Oncol. 2011 Mar;98(3):382-6
pubmed: 21339008
Med Phys. 2002 Jul;29(7):1590-8
pubmed: 12148742
Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):89-105
pubmed: 12694827
Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):273-9
pubmed: 18786784
Blood. 1998 Aug 15;92(4):1455-6
pubmed: 9694737
Leuk Res. 2011 Mar;35(3):310-6
pubmed: 20832860
Radiother Oncol. 2012 Feb;102(2):315-20
pubmed: 21724284
Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):180-189
pubmed: 30205123
Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1259-67
pubmed: 17336225
Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1260-9
pubmed: 19251098
Biol Blood Marrow Transplant. 2017 Jul;23(7):1110-1116
pubmed: 28396164
Med Dosim. 2012 Autumn;37(3):314-20
pubmed: 22326734
Int J Radiat Oncol Biol Phys. 2016 Nov 1;96(3):688-95
pubmed: 27681766
Med Phys. 2005 Oct;32(10):3214-24
pubmed: 16279075
J Appl Clin Med Phys. 2004 Autumn;5(4):71-9
pubmed: 15738922
Int J Radiat Oncol Biol Phys. 1997 Apr 1;38(1):197-206
pubmed: 9212024
Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):513-521
pubmed: 30807822
Phys Med Biol. 2000 Dec;45(12):3545-62
pubmed: 11131183

Auteurs

Darren Zuro (D)

Department of Radiation Oncology, Beckman Research Institute, City of Hope, Duarte, USA; Department of Radiation Oncology, University of Minnesota, Minneapolis, USA.

Stefano Vagge (S)

Deparment of Medical Imaging and Radiation Sciences, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Sara Broggi (S)

Department of Medical Physics, San Raffaele Scientific Institute, Milan, Italy.

Stefano Agostinelli (S)

Deparment of Medical Imaging and Radiation Sciences, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Yutaka Takahashi (Y)

Department of Radiation Oncology, Osaka University, Suita, Japan.

Jamison Brooks (J)

Department of Radiation Oncology, Beckman Research Institute, City of Hope, Duarte, USA.

Paulina Leszcynska (P)

Department of Radiotherapy Planning, Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland.

An Liu (A)

Department of Radiation Oncology, Beckman Research Institute, City of Hope, Duarte, USA.

Claudio Zucchetti (C)

Department of Radiation Oncology, University of Perugia, Italy.

Simonetta Saldi (S)

Department of Radiation Oncology, University of Nantes, France.

Chunhui Han (C)

Department of Radiation Oncology, Beckman Research Institute, City of Hope, Duarte, USA.

Mauro Cattaneo (M)

Department of Medical Physics, San Raffaele Scientific Institute, Milan, Italy.

Sebastian Giebel (S)

Department of Radiotherapy Planning, Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland.

Marc Andre Mahe (MA)

Department of Radiation Oncology, University of Nantes, France.

James F Sanchez (JF)

Department of Radiation Oncology, Beckman Research Institute, City of Hope, Duarte, USA.

Parham Alaei (P)

Department of Radiation Oncology, University of Minnesota, Minneapolis, USA.

Chiara Anna (C)

Department of Medical Physics, San Raffaele Scientific Institute, Milan, Italy.

Kathryn Dusenbery (K)

Department of Radiation Oncology, University of Minnesota, Minneapolis, USA.

Antonio Pierini (A)

Division of Hematology and Clinical Immunology, Department of Medicine, University of Perugia, Italy.

Guy Storme (G)

Department of Radiotherapy UZ Brussel, Belgium.

Cynthia Aristei (C)

Department of Radiation Oncology, University of Nantes, France.

Jeffrey Y C Wong (JYC)

Department of Radiation Oncology, Beckman Research Institute, City of Hope, Duarte, USA.

Susanta Hui (S)

Department of Radiation Oncology, Beckman Research Institute, City of Hope, Duarte, USA. Electronic address: shui@coh.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH